⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12640352 | 0.83 | — | — | |
| SCHEMBL16715408 | 0.83 | — | — | |
| SCHEMBL27941690 | 0.80 | TAAR1 (0.45) | — | |
| SCHEMBL10159754 | 0.80 | GABRA1 (0.37) | — | |
| SCHEMBL8824490 | 0.78 | TNKS2 (0.37) | — | |
| SCHEMBL16564412 | 0.77 | GAA (0.40) | — | |
| SCHEMBL27199094 | 0.77 | ALOX15 (0.38) | — | |
| SCHEMBL15978541 | 0.77 | IDH1 (0.53) | — | |
| SCHEMBL9769265 | 0.77 | — | — | |
| SCHEMBL27199091 | 0.74 | NPSR1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10689309-B1 | Fused-ring alkane fuel and photocatalytic preparation process thereof | TIANJIN UNIVERSITY (CN) | 2020-06-23 | — | — | US | claimed |
| US-20200181040-A1 | Fused-ring alkane fuel and photocatalytic preparation process thereof | TIANJIN UNIVERSITY (CN) | 2020-06-11 | — | — | US | claimed |
| WO-2020010494-A1 | FUSED CYCLOALKANE FUEL AND PHOTOCATALYTIC PREPARATION METHOD THEREOF | 天津大学 | 2020-01-16 | — | — | WO | claimed |
| CN-108865298-B | Fused ring alkane fuel and photocatalytic preparation method thereof | 天津大学 | 2019-07-26 | — | — | CN | claimed |
| CN-108865298-A | Fused ring alkane fuel and photocatalytic preparation method thereof | 天津大学 | 2018-11-23 | — | — | CN | claimed |
| EP-4359382-A1 | TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS | Chevron Phillips Chemical Company LP (US) | 2024-05-01 | — | — | EP | disclosed |
| CN-117881658-A | Two-step synthesis of pyrrole compounds from furan compounds | 切弗朗菲利浦化学公司 | 2024-04-12 | — | — | CN | disclosed |
| US-11608317-B2 | Two-step synthesis of pyrrole compounds from furan compounds | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2023-03-21 | — | — | US | disclosed |
| US-11578347-B2 | Anaerobic fermentative production of furandimethanol and enzymatic production of furandicarboxylic acid | BRASKEM S.A. (BR) | 2023-02-14 | — | — | US | disclosed |
| US-20220298109-A1 | TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2022-09-22 | — | — | US | disclosed |
| WO-2022197944-A1 | TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2022-09-22 | — | — | WO | disclosed |
| US-20210206763-A1 | Anti-Proliferative Agents | PHEON THERAPEUTICS LTD (GB) | 2021-07-08 | — | — | US | disclosed |
| US-20080176870-A1 | Heterobicyclic metalloprotease inhibitors | NOLTE BERT | 2008-07-24 | — | — | US | disclosed |
| WO-2008063669-A1 | HETEROBICYCLIC MATRIX METALLOPROTEASE INHIBITORS | ALANTOS PHARMACEUTICALS HOLDING, INC. (US) | 2008-05-29 | — | — | WO | disclosed |
| WO-2008063667-A1 | HETEROTRICYCLIC METALLOPROTEASE INHIBITORS | ALANTOS PHARMACEUTICALS HOLDING, INC. (US) | 2008-05-29 | — | — | WO | disclosed |
| US-20080021024-A1 | Metalloprotease inhibitors | ALANTOS PHARMACEUTICALS HOLDING, INC. | 2008-01-24 | — | — | US | disclosed |
| WO-2007139856-A2 | HETEROBICYCLIC METALLOPROTEASE INHIBITORS | ALANTOS PHARMACEUTICALS, INC. (US) | 2007-12-06 | — | — | WO | disclosed |
| US-7285565-B2 | Benzamides and related inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-10-23 | — | — | US | disclosed |
| US-20070155738-A1 | Heterobicyclic metalloprotease inhibitors | ALANTOS PHARMACEUTICALS, INC. | 2007-07-05 | — | — | US | disclosed |
| US-20070155737-A1 | Heterobicyclic metalloprotease inhibitors | ALANTOS PHARMACEUTICALS, INC. | 2007-07-05 | — | — | US | disclosed |